Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,784 | 185 | 73.8% |
| Unspecified | $1,400 | 2 | 21.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 4.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $1,619 | 8 | $0 (2022) |
| Novo Nordisk Inc | $1,177 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $612.17 | 32 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $487.02 | 8 | $0 (2022) |
| ABBVIE INC. | $438.14 | 8 | $0 (2023) |
| Lilly USA, LLC | $367.26 | 12 | $0 (2024) |
| Amgen Inc. | $247.52 | 12 | $0 (2024) |
| Allergan, Inc. | $153.38 | 5 | $0 (2020) |
| SI-BONE, Inc. | $146.94 | 1 | $0 (2019) |
| Boston Scientific Corporation | $135.68 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.41 | 21 | Lilly USA, LLC ($129.54) |
| 2023 | $698.94 | 29 | Lilly USA, LLC ($174.13) |
| 2022 | $924.67 | 31 | ABBVIE INC. ($206.83) |
| 2021 | $464.00 | 14 | AbbVie Inc. ($211.30) |
| 2020 | $1,251 | 25 | Bayer HealthCare Pharmaceuticals Inc. ($700.00) |
| 2019 | $1,461 | 32 | Bayer HealthCare Pharmaceuticals Inc. ($700.00) |
| 2018 | $700.43 | 29 | Novo Nordisk Inc ($268.66) |
| 2017 | $505.53 | 7 | SANOFI-AVENTIS U.S. LLC ($300.00) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Bone Health | ||||||
| 09/26/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: Allergy/Immunology | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Biological | ||||||
| 08/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiology | ||||||
| 07/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: NEUROLOGY | ||||||
| 07/08/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $39.53 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Obesity | ||||||
| 05/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: VACCINES | ||||||
| 03/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.32 | General |
| 03/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/31/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Neurology | ||||||
| 01/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Inflammation | ||||||
| 01/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Diabetes | ||||||
| 12/27/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: VACCINES | ||||||
| 11/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Obesity | ||||||
| 11/06/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: CONTRACEPTIVE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BAY 94-8862 ph 3 conventional in diab nephropathy | Bayer HealthCare Pharmaceuticals Inc. | $1,400 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 900 | 1,261 | $210,647 | $89,430 |
| 2022 | 16 | 899 | 1,333 | $219,511 | $92,769 |
| 2021 | 15 | 784 | 1,137 | $197,041 | $84,937 |
| 2020 | 15 | 820 | 1,277 | $212,616 | $79,713 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 182 | 182 | $48,594 | $25,209 | 51.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 262 | $64,452 | $23,025 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 260 | $43,680 | $15,991 | 36.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 175 | 175 | $26,775 | $13,353 | 49.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $5,302 | $2,727 | 51.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $5,745 | $2,644 | 46.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $3,822 | $1,826 | 47.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 31 | 34 | $4,794 | $1,488 | 31.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $1,599 | $1,351 | 84.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 23 | 102 | $1,122 | $495.92 | 44.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $546.00 | $461.16 | 84.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 16 | $1,200 | $342.16 | 28.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 12 | $1,116 | $326.49 | 29.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $650.00 | $110.87 | 17.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 70 | $1,120 | $51.53 | 4.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 13 | $130.00 | $28.60 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 278 | $68,388 | $24,906 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 152 | 152 | $40,584 | $21,558 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 288 | $48,384 | $16,815 | 34.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 157 | 157 | $24,021 | $13,016 | 54.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 39 | 41 | $5,143 | $2,797 | 54.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $5,910 | $2,708 | 45.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 48 | 58 | $8,178 | $2,552 | 31.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $5,362 | $2,522 | 47.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $3,276 | $1,477 | 45.1% |
About Dr. Louis Maletz, MD
Dr. Louis Maletz, MD is a Family Medicine healthcare provider based in Poway, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013983055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Louis Maletz, MD has received a total of $6,484 in payments from pharmaceutical and medical device companies, with $478.41 received in 2024. These payments were reported across 188 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,784).
As a Medicare-enrolled provider, Maletz has provided services to 3,403 Medicare beneficiaries, totaling 5,008 services with total Medicare billing of $346,848. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Poway, CA
- Active Since 02/28/2006
- Last Updated 08/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1013983055
Products in Payments
- Non-Covered $1,400
- FARXIGA (Drug) $580.72
- Ozempic (Drug) $539.01
- UBRELVY (Drug) $426.16
- TOUJEO (Drug) $347.87
- MOUNJARO (Drug) $302.80
- Tresiba (Drug) $273.93
- Kerendia (Drug) $218.63
- iFuse Implant (Device) $146.94
- WATCHMAN Access System (Device) $135.68
- Otezla (Drug) $135.13
- Rybelsus (Drug) $128.15
- SOLIQUA (Drug) $124.99
- LINZESS (Drug) $104.38
- LEQVIO (Drug) $90.67
- Victoza (Drug) $89.29
- TRELEGY ELLIPTA (Drug) $84.91
- EVENITY (Biological) $70.10
- Omnia (Device) $67.95
- Wegovy (Drug) $65.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Poway
Susan Meram, Md, MD
Family Medicine — Payments: $4,661
Dr. Ludmilla Ionescu, M.d, M.D
Family Medicine — Payments: $2,119
Richard Putnam, Md, MD
Family Medicine — Payments: $1,571
Dr. Yusra Mir, M.d, M.D
Family Medicine — Payments: $494.14
Carol Cornelius, Md, MD
Family Medicine — Payments: $289.82
Vivek Nazareth, Md, MD
Family Medicine — Payments: $264.94